Her primary scientific interests are in Immunology, Internal medicine, Viral load, Acquired immunodeficiency syndrome and Virology. Her research integrates issues of Cerebrospinal fluid and Nested polymerase chain reaction in her study of Immunology. Her Internal medicine research integrates issues from Gastroenterology and Diabetes mellitus.
Her work focuses on many connections between Viral load and other disciplines, such as Raltegravir Potassium, that overlap with her field of interest in Elvitegravir and Bictegravir. Her Acquired immunodeficiency syndrome research incorporates elements of Epidemiology, Cohort study, Mortality rate, Confidence interval and Cohort. Her study in the field of Lentivirus is also linked to topics like Human genetic variation.
Her main research concerns Internal medicine, Immunology, Virology, Viral load and Gastroenterology. Her work carried out in the field of Internal medicine brings together such families of science as Lamivudine and Ritonavir. Antonella Castagna interconnects Cerebrospinal fluid, Acquired immunodeficiency syndrome and Cohort in the investigation of issues within Immunology.
Antonella Castagna combines subjects such as Integrase inhibitor, Raltegravir and Genotype with her study of Virology. Her Viral load study integrates concerns from other disciplines, such as Protease inhibitor, Antiretroviral therapy, Viremia, Retrospective cohort study and Drug resistance. Her work in Gastroenterology covers topics such as Pharmacology which are related to areas like Enfuvirtide.
Antonella Castagna mostly deals with Internal medicine, Regimen, Cohort, Cohort study and Retrospective cohort study. Her Internal medicine research includes elements of Gastroenterology and Viral load. Her biological study spans a wide range of topics, including Discontinuation, Lamivudine, Abacavir, Dolutegravir and Cobicistat.
Her Cohort research incorporates elements of Protease inhibitor and Observational study. Her research investigates the connection with Protease inhibitor and areas like Antiretroviral treatment which intersect with concerns in Virology. Her work deals with themes such as Asymptomatic, Hodgkin lymphoma, Cumulative incidence and Sarcoma, which intersect with Cohort study.
Internal medicine, Emergency department, Disease, Discontinuation and Dolutegravir are her primary areas of study. Antonella Castagna regularly ties together related areas like Gastroenterology in her Internal medicine studies. Her Emergency department study also includes
Her research integrates issues of Inflammation, Cancer and Outbreak in her study of Disease. Her research in Dolutegravir intersects with topics in Retrospective cohort study, Reverse-transcriptase inhibitor, Integrase inhibitor and Coinfection, Virus. Her Interquartile range study combines topics in areas such as Odds ratio and Confidence interval.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1
Jacques Fellay;Kevin V. Shianna;Dongliang Ge;Sara Colombo.
Science (2007)
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
Christoph D. Spinner;Robert L. Gottlieb;Gerard J. Criner;José Ramón Arribas López.
JAMA (2020)
Common genetic variation and the control of HIV-1 in humans.
Jacques Fellay;Dongliang Ge;Kevin V. Shianna;Sara Colombo.
PLOS Genetics (2009)
Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system
P. Cinque;M. Brytting;B. Wahren;A. Linde.
The Lancet (1993)
Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE).
Amanda Mocroft;Jens D Lundgren;Jens D Lundgren;Miriam Lewis Sabin;Antonella d'Arminio Monforte.
PLOS Medicine (2013)
Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study
Antonella Castagna;Franco Maggiolo;Giovanni Penco;David Wright.
The Journal of Infectious Diseases (2014)
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration
Charlotte Lewden;Vincent Bouteloup;Stéphane De Wit.
International Journal of Epidemiology (2012)
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study.
Corrado Campochiaro;Emanuel Della-Torre;Giulio Cavalli;Giacomo De Luca.
European Journal of Internal Medicine (2020)
Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients.
Paola Cinque;Luca Vago;Helena Dahl;Maria Brytting.
AIDS (1996)
Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement.
L. M. E. Grimaldi;G. V. Martino;D. M. Franciotta;R. Brustia.
Annals of Neurology (1991)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Vita-Salute San Raffaele University
University of Modena and Reggio Emilia
University of Milan
Catholic University of the Sacred Heart
University of Siena
University College London
Vita-Salute San Raffaele University
Vita-Salute San Raffaele University
University College London
Vita-Salute San Raffaele University
University of Jyväskylä
Taiwan Semiconductor Manufacturing Company (United States)
East China University of Science and Technology
University of Cambridge
Zhejiang University
Northeastern University
University of Turin
University of Las Palmas de Gran Canaria
Leiden University
University of L'Aquila
Nathan Kline Institute for Psychiatric Research
German Sport University Cologne
Georgia State University
University of Missouri
Mount Sinai Morningside
Harvard University